Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03398941
Other study ID # LC2017L01
Secondary ID
Status Recruiting
Phase N/A
First received January 7, 2018
Last updated January 7, 2018
Start date February 1, 2018
Est. completion date May 1, 2019

Study information

Verified date January 2018
Source Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Contact Chen yingtai, PhD
Phone +8618600258827
Email yingtai.chen@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial


Description:

The trial is funded by Cancer Foundation of China. The trial is prepared to be registered on the clinicaltrail.gov.

Quality assurance plan: every participant is enrolled or excluded by two practiced investigators. And two investigators participated in all steps of the trail, including the record of the data, and the investigators will compare the data. If the data is consistent, the investigators would record the data; if not, the data would be checked and decided by the two investigators. All the steps and data are site monitored and audited by the workers of research and financial department of National Cancer Center/ Cancer Hospital, Chinese Academy of Medical Sciences.

Data check: the investigators compare data entered into the registry against predefined rules for range or consistency with other data fields in the registry. Source data verification to assess the accuracy, completeness, or representativeness of registry data by comparing the data to external data sources, including medical records and electronic case report forms.

Data dictionary that contains detailed descriptions of each variable used by the registry, including the source of the variable, coding information, and normal ranges if relevant.

Standard Operating Procedures to address registry operations and analysis activities, such as participants recruitment, data collection, data management, data analysis, reporting for adverse events, and change management. All registry operations would be done according to specific steps, and by two practiced investigators.

Sample size assessment to specify the number of participants or participant years necessary to demonstrate an effect. According to the formula to differ advantages and disadvantages, the investigators need at least 70 participants to take part in the trail.

The investigators can recruit about 150 participants according to previous experiences.

Plan for missing data: the investigators would collect as much data as possible, and the investigators exclude the participants who cannot cooperate on recruitment. And the investigators manage situations according to statistical principles where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results.

Statistical analysis plan: Kaplan-Meier method would be used to analyze the difference of survival time between the two groups, and the local control rate of the two groups would be compared by chi square test. Statistical analyses would be performed by using IBM SPSS Statistics(version 20; IBM, Chicago, USA). The level of significance is defined as P < 0.05.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date May 1, 2019
Est. primary completion date January 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Pancreatectomy patients

Exclusion Criteria:

- Treated by chemotherapy or radiotherapy before With distant organ metastasis Cannot tolerate surgery

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide
Long-Period Octreotide 20mg one week before operation combine Short Period Octreotide 0.3mg during postoperative five days.

Locations

Country Name City State
China National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing

Sponsors (1)

Lead Sponsor Collaborator
Chengfeng Wang

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary pancreatic fistula three week after operation
Primary delayed gastric emptying three week after operation
Primary intra-abdominal fluid collections three week after operation
Primary wound infection three week after operation
Primary Bile leak three week after operation
Primary Abdominal bleeding three week after operation
See also
  Status Clinical Trial Phase
Recruiting NCT04205058 - Coffee After Pancreatic Surgery N/A
Completed NCT02971579 - A Register on the Quality of ERCP and Training of Endoscopists in Italy
Not yet recruiting NCT01900938 - Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP N/A
Completed NCT01427725 - Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
Not yet recruiting NCT05954221 - Red Cell Lysis Buffer Application Versus Conventional Sample Processing in EUS-FNB N/A
Enrolling by invitation NCT02471170 - Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
Completed NCT04705740 - Influence of the Endoscopists and Endoscopic Retrograde CholangioPanceratography
Recruiting NCT04259580 - Calgary Registry for Advanced and Therapeutic Endoscopy
Recruiting NCT04291651 - UCSF PANC Cyst Registry
Enrolling by invitation NCT03234543 - Remote Ischemic Conditioning in Abdominal Surgery N/A
Completed NCT02916199 - Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method N/A
Completed NCT03717298 - Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma Phase 2
Recruiting NCT03334708 - A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Recruiting NCT05249400 - Effect of Off-site Assistance on Success Rate of Selective Cannulation During hands-on ERCP Training N/A
Recruiting NCT05824403 - PAncreatic Disease Cohort of TOuLouse
Active, not recruiting NCT03269994 - Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? Phase 3
Enrolling by invitation NCT04329039 - Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics Phase 2/Phase 3
Completed NCT03198871 - IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population Phase 4
Completed NCT02337673 - Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography
Completed NCT01964430 - Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) Phase 3